These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12110749)

  • 1. The antiphospholipid syndrome.
    Avcin T; Kveder T; Rozman B
    N Engl J Med; 2002 Jul; 347(2):145-6; author reply 145-6. PubMed ID: 12110749
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.
    Meroni PL; Raschi E; Camera M; Testoni C; Nicoletti F; Tincani A; Khamashta MA; Balestrieri G; Tremoli E; Hess DC
    J Autoimmun; 2000 Sep; 15(2):237-40. PubMed ID: 10968917
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of antiphospholipid antibodies.
    de Groot PG; Derksen RH
    Neth J Med; 2004 Sep; 62(8):267-72. PubMed ID: 15588066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do antiphospholipid antibodies bind beta2-glycoprotein I?
    Giles IP; Isenberg DA; Latchman DS; Rahman A
    Arthritis Rheum; 2003 Aug; 48(8):2111-21. PubMed ID: 12905463
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction.
    Koike T; Ichikawa K; Atsumi T; Kasahara H; Matsuura E
    J Autoimmun; 2000 Sep; 15(2):97-100. PubMed ID: 10968892
    [No Abstract]   [Full Text] [Related]  

  • 6. Endothelial cell activation by antiphospholipid antibodies.
    Meroni PL; Raschi E; Testoni C; Borghi MO
    Clin Immunol; 2004 Aug; 112(2):169-74. PubMed ID: 15240160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta 2 Glycoprotein I--a key player in the antiphospholipid syndrome.
    Lutters BC; de Groot PG; Derksen RH
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):958-62. PubMed ID: 12455190
    [No Abstract]   [Full Text] [Related]  

  • 8. The antiphospholipid/cofactor syndromes.
    Alarcón-Segovia D; Cabral AR
    J Rheumatol; 1996 Aug; 23(8):1319-22. PubMed ID: 8856607
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?
    de Moerloose P; Reber G
    J Thromb Haemost; 2004 Jul; 2(7):1071-3. PubMed ID: 15219188
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology of the antiphospholipid syndrome.
    de Groot PG; Derksen RH
    J Thromb Haemost; 2005 Aug; 3(8):1854-60. PubMed ID: 16102052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations.
    Blank M; Shoenfeld Y
    Clin Immunol; 2004 Aug; 112(2):190-9. PubMed ID: 15240163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of Japanese researchers to progress in the study of allergy and collagen disease in the last 100 years: Antiphospholipid syndrome].
    Koike T
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91(9):2630-3. PubMed ID: 12373885
    [No Abstract]   [Full Text] [Related]  

  • 13. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.
    Bas de Laat H; Derksen RH; de Groot PG
    Clin Immunol; 2004 Aug; 112(2):161-8. PubMed ID: 15240159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
    Marai I; Tincani A; Balestrieri G; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?
    Galli M
    Thromb Res; 2004; 114(5-6):597-601. PubMed ID: 15507297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.
    Atsumi T; Amengual O; Yasuda S; Matsuura E; Koike T
    Autoimmunity; 2005 Aug; 38(5):377-81. PubMed ID: 16227153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.